Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease
- PMID:15201484
- DOI: 10.3233/jad-2004-6310
Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease
Abstract
Metals are found associated with beta-pleated sheets of Abeta42 in vivo and may be involved in their formation. Metal chelation has been proposed as a therapy for Alzheimer's disease on the basis that it may safely dissolve precipitated Abeta peptides. We have followed fibrillisation of Abeta42 in the presence of an additional metal ion (Al(III), Fe(III), Zn(II), Cu(II)) over a period of 32 weeks and we have investigated the dissolution of these aged peptide aggregates in the presence of both desferrioxamine (DFO) and ethylenediaminetetraacetic acid (EDTA). Abeta42 either alone or in the presence of Al(III) or Fe(III) formed beta-pleated sheets of plaque-like amyloids which were dissolved upon incubation with either chelator. Zn(II) inhibited whilst Cu(II) prevented the formation of beta-pleated sheets of Abeta42and neither of these influences were affected by incubation of the aged peptide aggregates with either DFO or EDTA. Freshly prepared solutions of Abeta42 either alone or in the presence of added Al(III) or Fe(III) did not form beta-pleated amyloid in the presence of DFO when incubated for up to 8 weeks. EDTA did not prevent beta-pleated amyloid formation in the same treatments and promoted beta-pleated amyloid formation in the presence of either Zn(II) or Cu(II). The presence of significant concentrations of Al(III) and Fe(III) as contaminants of 'Abeta42 only' preparations suggested that both of these metals were involved in either triggering the formation or stabilising the structure of beta-pleated amyloid. If the formation of such amyloid is critical to the aetiology of AD then the chelation of Al(III) and Fe(III) may prove to be a protective mechanism whilst the chelation of Cu(II) and Zn(II) without also chelating Al(III) and Fe(III) might actually exacerbate the condition.
Similar articles
- Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.Tahmasebinia F, Emadi S.Tahmasebinia F, et al.Biometals. 2017 Apr;30(2):285-293. doi: 10.1007/s10534-017-0005-2. Epub 2017 Mar 10.Biometals. 2017.PMID:28281098
- Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease.Exley C.Exley C.J Alzheimers Dis. 2006 Nov;10(2-3):173-7. doi: 10.3233/jad-2006-102-305.J Alzheimers Dis. 2006.PMID:17119286Review.
- Nucleoside-2',3'/3',5'-bis(thio)phosphate antioxidants are also capable of disassembly of amyloid beta42-Zn(ii)/Cu(ii) aggregates via Zn(ii)/Cu(ii)-chelation.Hevroni BL, Major DT, Dixit M, Mhashal AR, Das S, Fischer B.Hevroni BL, et al.Org Biomol Chem. 2016 May 18;14(20):4640-53. doi: 10.1039/c6ob00613b.Org Biomol Chem. 2016.PMID:27109038
- Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, Zatta P.Bolognin S, et al.Int J Biochem Cell Biol. 2011 Jun;43(6):877-85. doi: 10.1016/j.biocel.2011.02.009. Epub 2011 Mar 3.Int J Biochem Cell Biol. 2011.PMID:21376832
- Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.Chaudhari V, Bagwe-Parab S, Buttar HS, Gupta S, Vora A, Kaur G.Chaudhari V, et al.Neurotox Res. 2023 Jun;41(3):270-287. doi: 10.1007/s12640-023-00634-7. Epub 2023 Jan 27.Neurotox Res. 2023.PMID:36705861Review.
Cited by
- Influence of Metal Cations on the Viscoelastic Properties ofEscherichia coli Biofilms.Sarlet A, Ruffine V, Blank KG, Bidan CM.Sarlet A, et al.ACS Omega. 2023 Jan 27;8(5):4667-4676. doi: 10.1021/acsomega.2c06438. eCollection 2023 Feb 7.ACS Omega. 2023.PMID:36777596Free PMC article.
- Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al.He C, Zhao X, Lei Y, Nie J, Lu X, Song J, Wang L, Li H, Liu F, Zhang Y, Niu Q.He C, et al.Mol Ther Nucleic Acids. 2021 Nov 11;26:1401-1417. doi: 10.1016/j.omtn.2021.11.010. eCollection 2021 Dec 3.Mol Ther Nucleic Acids. 2021.PMID:34900398Free PMC article.
- Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L.Zucca FA, et al.Prog Neurobiol. 2017 Aug;155:96-119. doi: 10.1016/j.pneurobio.2015.09.012. Epub 2015 Oct 9.Prog Neurobiol. 2017.PMID:26455458Free PMC article.Review.
- Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods.Daugherty AM, Raz N.Daugherty AM, et al.Neuropsychol Rev. 2015 Sep;25(3):272-87. doi: 10.1007/s11065-015-9292-y. Epub 2015 Aug 7.Neuropsychol Rev. 2015.PMID:26248580Free PMC article.Review.
- Graphene based electrochemical immunosensor for the ultra-sensitive label free detection of Alzheimer's beta amyloid peptides Aβ(1-42).Abbasi HY, Tehrani Z, Devadoss A, Ali MM, Moradi-Bachiller S, Albani D, Guy OJ.Abbasi HY, et al.Nanoscale Adv. 2021 Feb 20;3(8):2295-2304. doi: 10.1039/d0na00801j. eCollection 2021 Apr 20.Nanoscale Adv. 2021.PMID:36133757Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical